Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +20.57% shed 2.31% to $324.21 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -2.23% rising 0.50% to 14,897.34 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -2.53% rising 1.09% to 35,294.76. The stock's fall snapped a four-day winning streak. Moderna Inc. closed $173.28 below its 52-week high ($497.49), which the company reached on August 10th.
The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -1.81% rose 0.39% to $109.33, Amgen Inc. /zigman2/quotes/209157011/composite AMGN -1.41% rose 0.51% to $207.84, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +0.43% rose 0.92% to $60.22. Trading volume (17.1 M) eclipsed its 50-day average volume of 16.7 M.